These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38728748)

  • 1. Coronary microvascular disease in women: epidemiology, mechanisms, evaluation, and treatment.
    Steinberg RR; Dragan A; Mehta PK; Toleva O
    Can J Physiol Pharmacol; 2024 Oct; 102(10):594-606. PubMed ID: 38728748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Coronary Microvascular Dysfunction Among Patients With Chest Pain and Nonobstructive Coronary Artery Disease.
    Sara JD; Widmer RJ; Matsuzawa Y; Lennon RJ; Lerman LO; Lerman A
    JACC Cardiovasc Interv; 2015 Sep; 8(11):1445-1453. PubMed ID: 26404197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in non-obstructive coronary artery disease.
    Waheed N; Elias-Smale S; Malas W; Maas AH; Sedlak TL; Tremmel J; Mehta PK
    Cardiovasc Res; 2020 Mar; 116(4):829-840. PubMed ID: 31958135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary Microvascular Dysfunction, Microvascular Angina, and Management.
    Löffler AI; Bourque JM
    Curr Cardiol Rep; 2016 Jan; 18(1):1. PubMed ID: 26694723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reappraisal of Ischemic Heart Disease.
    Kaski JC; Crea F; Gersh BJ; Camici PG
    Circulation; 2018 Oct; 138(14):1463-1480. PubMed ID: 30354347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary endothelial dysfunction in non-obstructive coronary artery disease: Risk, pathogenesis, diagnosis and therapy.
    Shaw J; Anderson T
    Vasc Med; 2016 Apr; 21(2):146-55. PubMed ID: 26675331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond Coronary Artery Disease: Assessing the Microcirculation.
    Pruthi S; Siddiqui E; Smilowitz NR
    Cardiol Clin; 2024 Feb; 42(1):125-135. PubMed ID: 37949533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary microvascular disease: The "Meeting Point" of Cardiology, Rheumatology and Endocrinology.
    Markousis-Mavrogenis G; Bacopoulou F; Mavragani C; Voulgari P; Kolovou G; Kitas GD; Chrousos GP; Mavrogeni SI
    Eur J Clin Invest; 2022 May; 52(5):e13737. PubMed ID: 34939183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aortic Stiffness Is Associated with Coronary Microvascular Dysfunction in Patients with Non-obstructive Coronary Artery Disease.
    Muroya T; Kawano H; Koga S; Ikeda S; Yamamoto F; Maemura K
    Intern Med; 2020; 59(23):2981-2987. PubMed ID: 33268696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary Microvascular Dysfunction: A Guide for Clinicians.
    Smati H; Sellke FW; Bourque JM; Qadeer YK; Niccoli G; Montone RA; Krittanawong C
    Am J Med; 2024 Sep; 137(9):810-817. PubMed ID: 38723930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epicardial adipose tissue attenuation on computed tomography in women with coronary microvascular dysfunction: A pilot, hypothesis generating study.
    Patel NH; Dave EK; Fatade YA; De Cecco CN; Ko YA; Chen Y; Sharma A; Rashid F; Vatsa N; Samady H; Toleva O; Quyyumi A; Mehta PK; Stillman AE
    Atherosclerosis; 2024 Aug; 395():118520. PubMed ID: 38944545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Incidence of Diabetes Mellitus in Coronary Microvascular Dysfunction: An Intriguing Association.
    Chhabra L; Kowlgi NG
    JACC Cardiovasc Interv; 2016 Feb; 9(4):395-396. PubMed ID: 26777324
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply: Low Incidence of Diabetes Mellitus in Coronary Microvascular Dysfunction: An Intriguing Association.
    Sara JD; Lerman A
    JACC Cardiovasc Interv; 2016 Feb; 9(4):396. PubMed ID: 26892090
    [No Abstract]   [Full Text] [Related]  

  • 14. Can Advanced Physiological Testing Bridge the Gap Between Chest Pain and Nonobstructive Coronary Atherosclerosis?
    Yoo SY; Samady H
    JACC Cardiovasc Interv; 2015 Sep; 8(11):1454-1456. PubMed ID: 26404198
    [No Abstract]   [Full Text] [Related]  

  • 15. Comprehensive treatment of microvascular angina in overweight women - a randomized controlled pilot trial.
    Bove KB; Nilsson M; Pedersen LR; Mikkelsen N; Suhrs HE; Astrup A; Prescott E
    PLoS One; 2020; 15(11):e0240722. PubMed ID: 33151955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traditional Cardiovascular Risk Factors and Coronary Microvascular Dysfunction in Women and Men: A Single-Center Study.
    Zornitzki L; Shetrit A; Freund O; Frydman S; Banai A; Amar Shamir R; Ben-Shoshan J; Arbel Y; Banai S; Konigstein M
    Cardiology; 2024; 149(5):455-462. PubMed ID: 38679011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial CT perfusion compared with transthoracic Doppler echocardiography in evaluation of the coronary microvascular function: An iPOWER substudy.
    Bechsgaard DF; Hove JD; Michelsen MM; Mygind ND; Pena A; Hansen PR; Hansen HS; Kastrup J; Høst N; Gustafsson I; Prescott E
    Clin Physiol Funct Imaging; 2021 Jan; 41(1):85-94. PubMed ID: 33030280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary microvascular dysfunction, microvascular angina, and treatment strategies.
    Marinescu MA; Löffler AI; Ouellette M; Smith L; Kramer CM; Bourque JM
    JACC Cardiovasc Imaging; 2015 Feb; 8(2):210-20. PubMed ID: 25677893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral Reactive Hyperemia Index and Coronary Microvascular Function in Women With no Obstructive CAD: The iPOWER Study.
    Michelsen MM; Mygind ND; Pena A; Aziz A; Frestad D; Høst N; Prescott E;
    JACC Cardiovasc Imaging; 2016 Apr; 9(4):411-7. PubMed ID: 27056160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reply: Microvascular Function in Ischemic Heart Disease: There May Be Room for Improvement.
    Sara JD; Lerman A
    JACC Cardiovasc Interv; 2016 Feb; 9(4):393. PubMed ID: 26892088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.